Prospective, randomized-controlled trial (RCT) comparing the use of Propofol and traditional sedation (Midazolam and Fentanyl) for diagnostic and screening endoscopies in patients with liver diseases. The investigators' working hypothesis is that the use of propofol will be translated in a shorter recovery and discharge times with a higher patient satisfaction and a decrease in general complications in the context of patients with advanced liver disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
60
1. Intervention group (Propofol): It will be administered as a monotherapy under direct gastroenterologists' 2. Control group (Midazolam with or without Fentanyl): Both drugs will be administered by the gastroenterologists
Department of Gastroenterology. Soroka University Medical Center
Beersheba, Beer-Sheva, Israel
Safety and efficacy of propofol in liver diseases
Time frame: At the end of each endoscopy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.